Takeda Pharmaceutical Co. Ltd reported a net profit of 192 billion JPY for FY2025, up 77.6% from the previous year, with revenue of 4.51 trillion JPY, a 1.7% decline year-over-year. The filing also explained financial measures including core operating profit and adjusted free cash flow to better assess ongoing performance.